Safety and Quality First
Plasma-derived medicinal products (PDMPs), safety and quality first
The medicines produced from plasma can be referred to as plasma-derived medicinal products. They are different from other pharmaceuticals due to their unique starting material, which is human plasma. Due to the specific starting material, there are also specific obligations for their manufacturing which are very much focused on safety. By taking extensive safety measures starting with donation and including specific steps in the fractionation (manufacturing) process, the plasma-derived medicinal products can be made safe and without risks for transmittable diseases via blood. Therefore it is of paramount importance that the quality of the whole chain from donor to patient follows high quality standards and good manufacturing practices (GMP) as laid out in international guidelines and in legislation.